末期腎不全(末期腎疾患):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)

◆英語タイトル:End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2016263
◆発行日:2018年04月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,000 ⇒換算¥212,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥636,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[末期腎不全(末期腎疾患):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)]についてメールでお問い合わせはこちら
※当調査レポートでは、末期腎不全(末期腎疾患)治療薬の世界市場動向について調査・分析し、以下の構成でお届けいたします。

・末期腎不全(末期腎疾患):適応症(疾患)の概要
・市販医薬品の状況
・世界のAPI(医薬品原薬)メーカー分析
・地域別APIメーカー状況(アメリカ、ヨーロッパ、中国など)
・末期腎不全(末期腎疾患)のフェーズ3治験薬の状況
・末期腎不全(末期腎疾患)治療薬の市場規模(販売予測)
・末期腎不全(末期腎疾患)の市販医薬品分析
 (医薬品名、説明、APIメーカー、承認状況、特許など)
・末期腎不全(末期腎疾患)のフェーズ3治験薬分析
・開発中止中の末期腎不全(末期腎疾患)治療薬剤
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s Report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Report is to understand the market and pipeline status of the drugs around the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2020. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market and Phase III therapeutics scenario for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD).
• A review of the marketed products under prescription for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) drugs.
• Coverage of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure to 2020.


*** レポート目次(コンテンツ)***

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2020
6. Marketed Drugs for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutic Market, US, Marketed Drugs by Application Type, 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutic Market, US, Marketed Drugs by Marketing Status, 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutic Market, US, (Year), 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Marketed Drugs, API Manufacturers by US DMF Status, 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs, API Manufacturers, Europe by Country, 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs, API Manufacturers, India by State, 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs, API Manufacturers, China by Province, 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs, API Manufacturers by Geography 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutic Market, Global Sales-2020 (in million USD)
• API Manufacturers for Drug, 2018
• Phase III Drugs for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), 2018
• Discontinued Drugs for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), 2018


List of Figures
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutic Market, US, Marketed Drugs by Application Type (%), 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutic Market, US, (Year), 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Marketed Drugs, API Manufacturers by US DMF Status (%), 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs, API Manufacturers, Europe by Country, 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs, API Manufacturers, India by State, 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs, API Manufacturers, China by Province, 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Drugs, API Manufacturers by Geography 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutic Market, Global Sales 2020 (in million USD)
• Drug, Patent/Exclusivity Expiry (Year), 2018


*** レポートのキーワード ***

末期腎不全(末期腎疾患)、薬剤、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品(市販薬)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2016263 )"末期腎不全(末期腎疾患):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)" (英文:End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。